Cargando…
The clinical course of a 79-year-old stroke survivor in the setting of a late-onset COVID-19 infection
Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (COVID-19), no specific antiviral drug has been proven effective for the treatment of patients with severe complications. However, a nucleoside prodrug remdesivir (GS-5734) was recently approved by...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753226/ https://www.ncbi.nlm.nih.gov/pubmed/35035971 http://dx.doi.org/10.1177/2050313X211066646 |